View by Year:
Lau J, Ilkhanizadeh S, Wang S, Miroshnikova YA, Salvatierra NA, Wong RA, Schmidt C, Weaver VM, Weiss WA, Persson AI
STAT3 blockade inhibits radiation-induced malignant progression in glioma.
Cancer research, Aug-17-2015;[Epub ahead of print].
Rivera LB, Meyronet D, Hervieu V, Frederick MJ, Bergsland E, Bergers G
Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy.
Cell reports, Apr-28-2015;11(4):577-91.  Epub 2015 Apr 16.
Northcott JM, Northey JJ, Barnes JM, Weaver VM
Fighting the force: Potential of homeobox genes for tumor microenvironment regulation.
Biochimica et biophysica acta, Apr-2015;1855(2):248-253.  Epub 2015 Mar 24.
Rivera LB, Bergers G
Intertwined regulation of angiogenesis and immunity by myeloid cells.
Trends in immunology, Apr-2015;36(4):240-9.  Epub 2015 Mar 11.
Tung JC, Barnes JM, Desai SR, Sistrunk C, Conklin MW, Schedin P, Eliceiri KW, Keely PJ, Seewaldt VL, Weaver VM
Tumor mechanics and metabolic dysfunction.
Free radical biology & medicine, Feb-2015;79:269-80.  Epub 2014 Dec 19.
Li N, Maly DJ, Chanthery YH, Sirkis DW, Nakamura JL, Berger MS, James CD, Shokat KM, Weiss WA, Persson AI
Radiotherapy followed by aurora kinase inhibition targets tumor-propagating cells in human glioblastoma.
Molecular cancer therapeutics, Feb-2015;14(2):419-28.  Epub 2014 Dec 18.
Cassereau L, Miroshnikova YA, Ou G, Lakins J, Weaver VM
A 3D tension bioreactor platform to study the interplay between ECM stiffness and tumor phenotype.
Journal of biotechnology, Jan-10-2015;193:66-9.  Epub 2014 Nov 27.
Swartling FJ, Čančer M, Frantz A, Weishaupt H, Persson AI
Deregulated proliferation and differentiation in brain tumors.
Cell and tissue research, Jan-2015;359(1):225-54.  Epub 2014 Nov 23.
Wang AS, Lodi A, Rivera LB, Izquierdo-Garcia JL, Firpo MA, Mulvihill SJ, Tempero MA, Bergers G, Ronen SM
HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.
NMR in biomedicine, Nov-2014;27(11):1361-70.  Epub 2014 Sep 9.
Rubashkin MG, Cassereau L, Bainer R, DuFort CC, Yui Y, Ou G, Paszek MJ, Davidson MW, Chen YY, Weaver VM
Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate.
Cancer research, Sep-1-2014;74(17):4597-611.
Paszek MJ, DuFort CC, Rossier O, Bainer R, Mouw JK, Godula K, Hudak JE, Lakins JN, Wijekoon AC, Cassereau L, Rubashkin MG, Magbanua MJ, Thorn KS, Davidson MW, Rugo HS, Park JW, Hammer DA, Giannone G, Bertozzi CR, Weaver VM
The cancer glycocalyx mechanically primes integrin-mediated growth and survival.
Nature, Jul-17-2014;511(7509):319-25.  Epub 2014 Jun 25.
Rubashkin MG, Ou G, Weaver VM
Deconstructing signaling in three dimensions.
Biochemistry, Apr-8-2014;53(13):2078-90.  Epub 2014 Mar 28.
Hyvönen M, Enbäck J, Huhtala T, Lammi J, Sihto H, Weisell J, Joensuu H, Rosenthal-Aizman K, El-Andaloussi S, Langel U, Närvänen A, Bergers G, Laakkonen P
Novel target for peptide-based imaging and treatment of brain tumors.
Molecular cancer therapeutics, Apr-2014;13(4):996-1007.  Epub 2014 Mar 26.
Mouw JK, Yui Y, Damiano L, Bainer RO, Lakins JN, Acerbi I, Ou G, Wijekoon AC, Levental KR, Gilbert PM, Hwang ES, Chen YY, Weaver VM
Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression.
Nature medicine, Apr-2014;20(4):360-7.  Epub 2014 Mar 16.
Rivera L, Pandika M, Bergers G
Escape mechanisms from antiangiogenic therapy: an immune cell's perspective.
Advances in experimental medicine and biology, 2014;772:83-99.
Ilkanizadeh S, Lau J, Huang M, Foster DJ, Wong R, Frantz A, Wang S, Weiss WA, Persson AI
Glial progenitors as targets for transformation in glioma.
Advances in cancer research, 2014;121:1-65.
Rivera LB, Bergers G
Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity.
Cancer cell, Dec-9-2013;24(6):687-9.
Fan QW, Cheng CK, Gustafson WC, Charron E, Zipper P, Wong RA, Chen J, Lau J, Knobbe-Thomsen C, Weller M, Jura N, Reifenberger G, Shokat KM, Weiss WA
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.
Cancer cell, Oct-14-2013;24(4):438-49.
Huang M, Weiss WA
Neuroblastoma and MYCN.
Cold Spring Harbor perspectives in medicine, Oct-2013;[epublish]3(10):a014415.
Bainer R, Weaver V
Cell biology. Strength under tension.
Science (New York, N.Y.), Aug-30-2013;341(6149):965-6.
Swartling FJ, Hede SM, Weiss WA
What underlies the diversity of brain tumors?
Cancer metastasis reviews, Jun-2013;32(1-2):5-24.
Jahangiri A, De Lay M, Miller LM, Carbonell WS, Hu YL, Lu K, Tom MW, Paquette J, Tokuyasu TA, Tsao S, Marshall R, Perry A, Bjorgan KM, Chaumeil MM, Ronen SM, Bergers G, Aghi MK
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research, Apr-1-2013;19(7):1773-83.  Epub 2013 Mar 21.
Swartling FJ, Bolin S, Phillips JJ, Persson AI
Signals that regulate the oncogenic fate of neural stem cells and progenitors.
Experimental neurology, Jan-31-2013;[Epub ahead of print].
Lu KV, Bergers G
Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma.
CNS oncology, Jan-2013;2(1):49-65.
Paszek MJ, DuFort CC, Rubashkin MG, Davidson MW, Thorn KS, Liphardt JT, Weaver VM
Scanning angle interference microscopy reveals cell dynamics at the nanoscale.
Nature methods, Aug-2012;[epublish]9(8):825-7.
Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.
Cancer cell, Jul-10-2012;22(1):21-35.
Chesler L, Weiss WA
Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.
Seminars in cancer biology, Oct-2011;21(4):245-55.  Epub 2011 Sep 21.